Camilla has worked as a patent attorney since 2003 and at Brann since 2013. She has extensive experience of intellectual property advice in life sciences and research and development. Her background in the commercialisation of research-based innovations has given her a broad understanding of how intellectual property, research and business development interact.

Camilla provides strategic intellectual property advice and assists companies with matters relating to international patent portfolios, freedom-to-operate analyses, due diligence processes and supplementary protection certificates for medicinal products (SPCs), as well as other intellectual property matters. Her specialist expertise includes genetic engineering, vaccines, molecular biology, microbiology, biochemistry and immunology.

In addition to her client work, Camilla is active in the professional organisations SIPF and AIPPI. She also regularly participates in national and international networks and forums within the field of intellectual property.